Cite
MLA Citation
G. Giordano et al.. “2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian "real life" study.” European journal of cancer, vol. 51, n.d., pp. S444–. http://access.bl.uk/ark:/81055/vdc_100030628218.0x000007